Browse by Journal or other publication
Jump to: 2019
Number of items: 1.
2019
Silva, W. and Cherchiglia, ML and Godman, Brian and Portela, MA and Izidoro, JB and Lana, AP and de Jesus, MA and Kambeba, AO and Dias, IC and Acurcio, FA and Andrade, EIG (2019) Evolution number of litigation cases and expenditure with monoclonal antibodies (MoAbs) (Bevacizumab, Cetuximab and Panitumumab) and tirosine kinase inhibitor (Regorafenib) for the treatment of cancer in Minas Gerais-Brazil : A preliminary analysis from 2009 to 2016. In: ISPOR 2019, 2019-05-18 - 2019-05-22.